TSUMURA & CO. Logo

TSUMURA & CO.

4540 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区赤坂二丁目17番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TSUMURA & CO. is a prominent Japanese pharmaceutical company specializing in Kampo medicine, which integrates traditional herbal practices with modern health solutions. The company offers a range of products, including prescription Kampo formulations, over-the-counter medications, and herbal bath salts, promoting a holistic approach to well-being. TSUMURA & CO. aims to foster “Cho-WA” or harmony between the mind, body, and society, reflecting its commitment to sustainable practices that benefit individuals and the environment. With a focus on innovation rooted in tradition, the company strives to navigate the Kampo value chain responsibly, ensuring a sustainable future for both people and the planet. Additionally, TSUMURA publishes "The Journal of Japanese Botany," contributing to the scientific discourse in herbal medicine.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TSUMURA & CO.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-08 07:37
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.7 KB
2025-07-01 09:20
Regulatory News Service
臨時報告書
Japanese 27.7 KB
2025-06-24 06:22
Regulatory News Service
内部統制報告書-第89期(2024/04/01-2025/03/31)
Japanese 25.7 KB
2025-06-24 06:21
Annual Report
有価証券報告書-第89期(2024/04/01-2025/03/31)
Japanese 3.5 MB
2025-06-24 06:21
Regulatory News Service
確認書
Japanese 8.9 KB
2025-06-11 06:35
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.8 KB
2025-05-12 07:16
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.0 KB
2025-04-07 07:10
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.9 KB
2025-03-10 07:05
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.1 KB
2025-03-03 08:27
Regulatory News Service
訂正臨時報告書
Japanese 30.2 KB
2025-02-20 07:30
Regulatory News Service
臨時報告書
Japanese 27.8 KB
2024-11-08 07:11
Regulatory News Service
確認書
Japanese 8.9 KB
2024-11-08 07:08
Interim Report
半期報告書-第89期(2024/04/01-2025/03/31)
Japanese 242.2 KB
2024-07-01 08:38
Regulatory News Service
臨時報告書
Japanese 24.0 KB
2024-06-27 08:16
Regulatory News Service
確認書
Japanese 8.9 KB

Automate Your Workflow. Get a real-time feed of all TSUMURA & CO. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TSUMURA & CO. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Antibiotice S.A. Logo
Manufactures FDA-approved generic drugs, sterile injectables, and APIs for global markets.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB